Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Association Between Amyloid and Tau Accumulation in Young Adults With Autosomal Dominant Alzheimer Disease.

Quiroz YT, Sperling RA, Norton DJ, Baena A, Arboleda-Velasquez JF, Cosio D, Schultz A, Lapoint M, Guzman-Velez E, Miller JB, Kim LA, Chen K, Tariot PN, Lopera F, Reiman EM, Johnson KA.

JAMA Neurol. 2018 Feb 12. doi: 10.1001/jamaneurol.2017.4907. [Epub ahead of print]

PMID:
29435558
2.

The Value of Pre-Screening in the Alzheimer's Prevention Initiative (API) Autosomal Dominant Alzheimer's Disease Trial.

Rios-Romenets S, Giraldo-Chica M, López H, Piedrahita F, Ramos C, Acosta-Baena N, Muñoz C, Ospina P, Tobón C, Cho W, Ward M, Langbaum JB, Tariot PN, Reiman EM, Lopera F.

J Prev Alzheimers Dis. 2018;5(1):49-54. doi: 10.14283/jpad.2017.44.

PMID:
29405233
3.

Erratum: Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.

Cornejo-Olivas M, Torres L, Velit-Salazar MR, Inca-Martinez M, Mazzetti P, Cosentino C, Micheli F, Perandones C, Dieguez E, Raggio V, Tumas V, Borges V, Ferraz HB, Rieder CRM, Shumacher-Schuh A, Velez-Pardo C, Jimenez-Del-Rio M, Lopera F, Chang-Castello J, Andreé-Munoz B, Waldherr S, Yearout D, Zabetian CP, Mata IF.

NPJ Parkinsons Dis. 2018 Jan 19;4:3. doi: 10.1038/s41531-017-0025-1. eCollection 2018.

4.

Dementia in Latin America: Assessing the present and envisioning the future.

Parra MA, Baez S, Allegri R, Nitrini R, Lopera F, Slachevsky A, Custodio N, Lira D, Piguet O, Kumfor F, Huepe D, Cogram P, Bak T, Manes F, Ibanez A.

Neurology. 2018 Jan 30;90(5):222-231. doi: 10.1212/WNL.0000000000004897. Epub 2018 Jan 5. Review.

5.

Differential Pattern of Phospholipid Profile in the Temporal Cortex from E280A-Familiar and Sporadic Alzheimer's Disease Brains.

Villamil-Ortiz JG, Barrera-Ocampo A, Arias-Londoño JD, Villegas A, Lopera F, Cardona-Gómez GP.

J Alzheimers Dis. 2018;61(1):209-219. doi: 10.3233/JAD-170554.

PMID:
29125487
6.

Subjective memory complaints in preclinical autosomal dominant Alzheimer disease.

Norton DJ, Amariglio R, Protas H, Chen K, Aguirre-Acevedo DC, Pulsifer B, Castrillon G, Tirado V, Munoz C, Tariot P, Langbaum JB, Reiman EM, Lopera F, Sperling RA, Quiroz YT.

Neurology. 2017 Oct 3;89(14):1464-1470. doi: 10.1212/WNL.0000000000004533. Epub 2017 Sep 6.

PMID:
28878053
7.

Parkinson's disease compromises the appraisal of action meanings evoked by naturalistic texts.

García AM, Bocanegra Y, Herrera E, Moreno L, Carmona J, Baena A, Lopera F, Pineda D, Melloni M, Legaz A, Muñoz E, Sedeño L, Baez S, Ibáñez A.

Cortex. 2017 Jul 17. pii: S0010-9452(17)30222-8. doi: 10.1016/j.cortex.2017.07.003. [Epub ahead of print]

PMID:
28764852
8.

Variable frequency of LRRK2 variants in the Latin American research consortium on the genetics of Parkinson's disease (LARGE-PD), a case of ancestry.

Cornejo-Olivas M, Torres L, Velit-Salazar MR, Inca-Martinez M, Mazzetti P, Cosentino C, Micheli F, Perandones C, Dieguez E, Raggio V, Tumas V, Borges V, Ferraz HB, Rieder CRM, Shumacher-Schuh A, Velez-Pardo C, Jimenez-Del-Rio M, Lopera F, Chang-Castello J, Andreé-Munoz B, Waldherr S, Yearout D, Zabetian CP, Mata IF.

NPJ Parkinsons Dis. 2017 Jun 2;3:19. doi: 10.1038/s41531-017-0020-6. eCollection 2017. Erratum in: NPJ Parkinsons Dis. 2018 Jan 19;4:3.

9.

Brain Information Sharing During Visual Short-Term Memory Binding Yields a Memory Biomarker for Familial Alzheimer's Disease.

Parra MA, Mikulan E, Trujillo N, Sala SD, Lopera F, Manes F, Starr J, Ibanez A.

Curr Alzheimer Res. 2017;14(12):1335-1347. doi: 10.2174/1567205014666170614163316.

PMID:
28641509
10.

Precuneus Failures in Subjects of the PSEN1 E280A Family at Risk of Developing Alzheimer's Disease Detected Using Quantitative Electroencephalography.

Ochoa JF, Alonso JF, Duque JE, Tobón CA, Baena A, Lopera F, Mañanas MA, Hernández AM.

J Alzheimers Dis. 2017;58(4):1229-1244. doi: 10.3233/JAD-161291.

PMID:
28550254
11.

Genetic Ancestry and Susceptibility to Late-Onset Alzheimer Disease (LOAD) in the Admixed Colombian Population.

Moreno DJ, Pino S, Ríos Á, Lopera F, Ostos H, Via M, Bedoya G.

Alzheimer Dis Assoc Disord. 2017 Jul-Sep;31(3):225-231. doi: 10.1097/WAD.0000000000000195.

PMID:
28369008
12.

Amyloid-beta immunotherapy: the hope for Alzheimer disease?

Barrera-Ocampo A, Lopera F.

Colomb Med (Cali). 2016 Dec 30;47(4):203-212. Review.

13.

Unspeakable motion: Selective action-verb impairments in Parkinson's disease patients without mild cognitive impairment.

Bocanegra Y, García AM, Lopera F, Pineda D, Baena A, Ospina P, Alzate D, Buriticá O, Moreno L, Ibáñez A, Cuetos F.

Brain Lang. 2017 May;168:37-46. doi: 10.1016/j.bandl.2017.01.005. Epub 2017 Jan 25.

PMID:
28131052
14.

Association of GWAS Top Genes With Late-Onset Alzheimer's Disease in Colombian Population.

Moreno DJ, Ruiz S, Ríos Á, Lopera F, Ostos H, Via M, Bedoya G.

Am J Alzheimers Dis Other Demen. 2017 Feb;32(1):27-35. doi: 10.1177/1533317516679303. Epub 2017 Jan 13.

PMID:
28084078
15.

Dementia, Preclinical Studies in Neurodegeneration and its Potential for Translational Medicine in South America.

Cardona-Gómez GP, Lopera F.

Front Aging Neurosci. 2016 Dec 20;8:304. doi: 10.3389/fnagi.2016.00304. eCollection 2016. Review.

16.

The Road Less Traveled: Alternative Pathways for Action-Verb Processing in Parkinson's Disease.

Abrevaya S, Sedeño L, Fitipaldi S, Pineda D, Lopera F, Buritica O, Villegas A, Bustamante C, Gomez D, Trujillo N, Pautassi R, Ibáñez A, García AM.

J Alzheimers Dis. 2017;55(4):1429-1435. doi: 10.3233/JAD-160737.

PMID:
27834777
17.

Successful Object Encoding Induces Increased Directed Connectivity in Presymptomatic Early-Onset Alzheimer's Disease.

Ochoa JF, Alonso JF, Duque JE, Tobón CA, Mañanas MA, Lopera F, Hernández AM.

J Alzheimers Dis. 2017;55(3):1195-1205.

18.

Mutations modifying sporadic Alzheimer's disease age of onset.

Vélez JI, Lopera F, Patel HR, Johar AS, Cai Y, Rivera D, Tobón C, Villegas A, Sepulveda-Falla D, Lehmann SG, Easteal S, Mastronardi CA, Arcos-Burgos M.

Am J Med Genet B Neuropsychiatr Genet. 2016 Dec;171(8):1116-1130. doi: 10.1002/ajmg.b.32493. Epub 2016 Aug 30.

PMID:
27573710
19.

Behavioral and Electrophysiological Correlates of Memory Binding Deficits in Patients at Different Risk Levels for Alzheimer's Disease.

Pietto M, Parra MA, Trujillo N, Flores F, García AM, Bustin J, Richly P, Manes F, Lopera F, Ibáñez A, Baez S.

J Alzheimers Dis. 2016 Jun 30;53(4):1325-40. doi: 10.3233/JAD-160056.

PMID:
27372640
20.

p120-catenin is necessary for neuroprotection induced by CDK5 silencing in models of Alzheimer's disease.

Uribe-Arias A, Posada-Duque RA, González-Billault C, Villegas A, Lopera F, Cardona-Gómez GP.

J Neurochem. 2016 Aug;138(4):624-39. doi: 10.1111/jnc.13697. Epub 2016 Jul 5.

21.

Blood biomarkers in a mouse model of CADASIL.

Primo V, Graham M, Bigger-Allen AA, Chick JM, Ospina C, Quiroz YT, Manent J, Gygi SP, Lopera F, D'Amore PA, Arboleda-Velasquez JF.

Brain Res. 2016 Aug 1;1644:118-26. doi: 10.1016/j.brainres.2016.05.008. Epub 2016 May 10.

22.

A Mutation in DAOA Modifies the Age of Onset in PSEN1 E280A Alzheimer's Disease.

Vélez JI, Rivera D, Mastronardi CA, Patel HR, Tobón C, Villegas A, Cai Y, Easteal S, Lopera F, Arcos-Burgos M.

Neural Plast. 2016;2016:9760314. doi: 10.1155/2016/9760314. Epub 2016 Jan 5.

23.

Cognitive Decline in a Colombian Kindred With Autosomal Dominant Alzheimer Disease: A Retrospective Cohort Study.

Aguirre-Acevedo DC, Lopera F, Henao E, Tirado V, Muñoz C, Giraldo M, Bangdiwala SI, Reiman EM, Tariot PN, Langbaum JB, Quiroz YT, Jaimes F.

JAMA Neurol. 2016 Apr;73(4):431-8. doi: 10.1001/jamaneurol.2015.4851.

24.

Novel cerebrotendinous xanthomatosis mutation causes familial early dementia in Colombia.

Giraldo-Chica M, Acosta-Baena N, Urbano L, Velilla L, Lopera F, Pineda N.

Biomedica. 2015 Oct-Dec;35(4):563-71. doi: 10.7705/biomedica.v35i4.2690.

25.

APOE*E2 allele delays age of onset in PSEN1 E280A Alzheimer's disease.

Vélez JI, Lopera F, Sepulveda-Falla D, Patel HR, Johar AS, Chuah A, Tobón C, Rivera D, Villegas A, Cai Y, Peng K, Arkell R, Castellanos FX, Andrews SJ, Silva Lara MF, Creagh PK, Easteal S, de Leon J, Wong ML, Licinio J, Mastronardi CA, Arcos-Burgos M.

Mol Psychiatry. 2016 Jul;21(7):916-24. doi: 10.1038/mp.2015.177. Epub 2015 Dec 1.

26.

Linkage and association analysis of ADHD endophenotypes in extended and multigenerational pedigrees from a genetic isolate.

Mastronardi CA, Pillai E, Pineda DA, Martinez AF, Lopera F, Velez JI, Palacio JD, Patel H, Easteal S, Acosta MT, Castellanos FX, Muenke M, Arcos-Burgos M.

Mol Psychiatry. 2016 Oct;21(10):1434-40. doi: 10.1038/mp.2015.172. Epub 2015 Nov 24.

27.

Diagnostic accuracy of CERAD total score in a Colombian cohort with mild cognitive impairment and Alzheimer's disease affected by E280A mutation on presenilin-1 gene.

Aguirre-Acevedo DC, Jaimes-Barragán F, Henao E, Tirado V, Muñoz C, Reiman EM, Tariot PN, Langbaum JB, Lopera F.

Int Psychogeriatr. 2016 Mar;28(3):503-10. doi: 10.1017/S1041610215001660. Epub 2015 Oct 19.

PMID:
26478578
28.

CAP--advancing the evaluation of preclinical Alzheimer disease treatments.

Reiman EM, Langbaum JB, Tariot PN, Lopera F, Bateman RJ, Morris JC, Sperling RA, Aisen PS, Roses AD, Welsh-Bohmer KA, Carrillo MC, Weninger S.

Nat Rev Neurol. 2016 Jan;12(1):56-61. doi: 10.1038/nrneurol.2015.177. Epub 2015 Sep 29. Review.

29.

Successful Scene Encoding in Presymptomatic Early-Onset Alzheimer's Disease.

Quiroz YT, Willment KC, Castrillon G, Muniz M, Lopera F, Budson A, Stern CE.

J Alzheimers Dis. 2015;47(4):955-64. doi: 10.3233/JAD-150214.

30.

Whole-genome sequencing suggests a chemokine gene cluster that modifies age at onset in familial Alzheimer's disease.

Lalli MA, Bettcher BM, Arcila ML, Garcia G, Guzman C, Madrigal L, Ramirez L, Acosta-Uribe J, Baena A, Wojta KJ, Coppola G, Fitch R, de Both MD, Huentelman MJ, Reiman EM, Brunkow ME, Glusman G, Roach JC, Kao AW, Lopera F, Kosik KS.

Mol Psychiatry. 2015 Nov;20(11):1294-300. doi: 10.1038/mp.2015.131. Epub 2015 Sep 1.

31.

Establishing Composite Cognitive Endpoints for Use in Preclinical Alzheimer's Disease Trials.

Langbaum JB, Hendrix S, Ayutyanont N, Bennett DA, Shah RC, Barnes LL, Lopera F, Reiman EM, Tariot PN.

J Prev Alzheimers Dis. 2015 Mar;2(1):2-3. No abstract available.

32.

Cortical dynamics and subcortical signatures of motor-language coupling in Parkinson's disease.

Melloni M, Sedeño L, Hesse E, García-Cordero I, Mikulan E, Plastino A, Marcotti A, López JD, Bustamante C, Lopera F, Pineda D, García AM, Manes F, Trujillo N, Ibáñez A.

Sci Rep. 2015 Jul 8;5:11899. doi: 10.1038/srep11899.

33.

Brain Imaging and Blood Biomarker Abnormalities in Children With Autosomal Dominant Alzheimer Disease: A Cross-Sectional Study.

Quiroz YT, Schultz AP, Chen K, Protas HD, Brickhouse M, Fleisher AS, Langbaum JB, Thiyyagura P, Fagan AM, Shah AR, Muniz M, Arboleda-Velasquez JF, Munoz C, Garcia G, Acosta-Baena N, Giraldo M, Tirado V, Ramírez DL, Tariot PN, Dickerson BC, Sperling RA, Lopera F, Reiman EM.

JAMA Neurol. 2015 Aug;72(8):912-9. doi: 10.1001/jamaneurol.2015.1099.

34.

Syntax, action verbs, action semantics, and object semantics in Parkinson's disease: Dissociability, progression, and executive influences.

Bocanegra Y, García AM, Pineda D, Buriticá O, Villegas A, Lopera F, Gómez D, Gómez-Arias C, Cardona JF, Trujillo N, Ibáñez A.

Cortex. 2015 Aug;69:237-54. doi: 10.1016/j.cortex.2015.05.022. Epub 2015 Jun 3.

PMID:
26103601
35.

Deciphering interference control in adults with ADHD by using distribution analyses and electromyographic activity.

Suarez I, Burle B, Tobon C, Pineda D, Lopera F, Hasbroucq T, Casini L.

Acta Psychol (Amst). 2015 Jul;159:85-92. doi: 10.1016/j.actpsy.2015.05.010. Epub 2015 Jun 8.

PMID:
26057599
36.

Memory binding and white matter integrity in familial Alzheimer's disease.

Parra MA, Saarimäki H, Bastin ME, Londoño AC, Pettit L, Lopera F, Della Sala S, Abrahams S.

Brain. 2015 May;138(Pt 5):1355-69. doi: 10.1093/brain/awv048. Epub 2015 Mar 11.

PMID:
25762465
37.

Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional study.

Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gutierrez Gomez M, Langois CM, Langbaum JB, Roontiva A, Thiyyagura P, Lee W, Ayutyanont N, Lopez L, Moreno S, Muñoz C, Tirado V, Acosta-Baena N, Fagan AM, Giraldo M, Garcia G, Huentelman MJ, Tariot PN, Lopera F, Reiman EM.

JAMA Neurol. 2015 Mar;72(3):316-24. doi: 10.1001/jamaneurol.2014.3314.

38.

Homozygosity of the autosomal dominant Alzheimer disease presenilin 1 E280A mutation.

Kosik KS, Muñoz C, Lopez L, Arcila ML, García G, Madrigal L, Moreno S, Ríos Romenets S, Lopez H, Gutierrez M, Langbaum JB, Cho W, Suliman S, Tariot PN, Ho C, Reiman EM, Lopera F.

Neurology. 2015 Jan 13;84(2):206-8. doi: 10.1212/WNL.0000000000001130. Epub 2014 Dec 3. No abstract available.

39.

Alzheimer's disease: initial clinical implementation of automated volumetry.

Herrera DA, Vargas J, Ochoa JF, Duque JE, Vargas SA, Lopera F, Castillo M.

Can J Neurol Sci. 2014 Sep;41(5):651-3. doi: 10.1017/cjn.2014.23. No abstract available.

PMID:
25373817
40.

Dual memory task impairment in E280A presenilin-1 mutation carriers.

MacPherson SE, Parra MA, Moreno S, Lopera F, Della Sala S.

J Alzheimers Dis. 2015;44(2):481-92. doi: 10.3233/JAD-140990.

PMID:
25352452
41.

Symptom onset in autosomal dominant Alzheimer disease: a systematic review and meta-analysis.

Ryman DC, Acosta-Baena N, Aisen PS, Bird T, Danek A, Fox NC, Goate A, Frommelt P, Ghetti B, Langbaum JB, Lopera F, Martins R, Masters CL, Mayeux RP, McDade E, Moreno S, Reiman EM, Ringman JM, Salloway S, Schofield PR, Sperling R, Tariot PN, Xiong C, Morris JC, Bateman RJ; Dominantly Inherited Alzheimer Network.

Neurology. 2014 Jul 15;83(3):253-60. doi: 10.1212/WNL.0000000000000596. Epub 2014 Jun 13. Review.

42.

The Alzheimer's prevention initiative composite cognitive test score: sample size estimates for the evaluation of preclinical Alzheimer's disease treatments in presenilin 1 E280A mutation carriers.

Ayutyanont N, Langbaum JB, Hendrix SB, Chen K, Fleisher AS, Friesenhahn M, Ward M, Aguirre C, Acosta-Baena N, Madrigal L, Muñoz C, Tirado V, Moreno S, Tariot PN, Lopera F, Reiman EM.

J Clin Psychiatry. 2014 Jun;75(6):652-60. doi: 10.4088/JCP.13m08927. Review.

43.

Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasis.

Sepulveda-Falla D, Barrera-Ocampo A, Hagel C, Korwitz A, Vinueza-Veloz MF, Zhou K, Schonewille M, Zhou H, Velazquez-Perez L, Rodriguez-Labrada R, Villegas A, Ferrer I, Lopera F, Langer T, De Zeeuw CI, Glatzel M.

J Clin Invest. 2014 Apr;124(4):1552-67. doi: 10.1172/JCI66407. Epub 2014 Feb 24.

44.

Spectral Analysis of EEG in Familial Alzheimer's Disease with E280A Presenilin-1 Mutation Gene.

Rodriguez R, Lopera F, Alvarez A, Fernandez Y, Galan L, Quiroz Y, Bobes MA.

Int J Alzheimers Dis. 2014;2014:180741. doi: 10.1155/2014/180741. Epub 2014 Jan 2.

45.

Origin of the PSEN1 E280A mutation causing early-onset Alzheimer's disease.

Lalli MA, Cox HC, Arcila ML, Cadavid L, Moreno S, Garcia G, Madrigal L, Reiman EM, Arcos-Burgos M, Bedoya G, Brunkow ME, Glusman G, Roach JC, Hood L, Kosik KS, Lopera F.

Alzheimers Dement. 2014 Oct;10(5 Suppl):S277-S283.e10. doi: 10.1016/j.jalz.2013.09.005. Epub 2013 Nov 13.

46.

An 1H-MRS framework predicts the onset of Alzheimer's disease symptoms in PSEN1 mutation carriers.

Londono AC, Castellanos FX, Arbelaez A, Ruiz A, Aguirre-Acevedo DC, Richardson AM, Easteal S, Lidbury BA, Arcos-Burgos M, Lopera F.

Alzheimers Dement. 2014 Sep;10(5):552-61. doi: 10.1016/j.jalz.2013.08.282. Epub 2013 Nov 13.

PMID:
24239247
47.

The cognitive structure of time estimation impairments in adults with attention deficit hyperactivity disorder.

Suarez I, Lopera F, Pineda D, Casini L.

Cogn Neuropsychol. 2013;30(4):195-207. doi: 10.1080/02643294.2013.842548. Epub 2013 Oct 10.

PMID:
24111987
48.

Ushering in the study and treatment of preclinical Alzheimer disease.

Langbaum JB, Fleisher AS, Chen K, Ayutyanont N, Lopera F, Quiroz YT, Caselli RJ, Tariot PN, Reiman EM.

Nat Rev Neurol. 2013 Jul;9(7):371-81. doi: 10.1038/nrneurol.2013.107. Epub 2013 Jun 11. Review. Erratum in: Nat Rev Neurol. 2013 Aug;9(8):418.

49.

Variants in triggering receptor expressed on myeloid cells 2 are associated with both behavioral variant frontotemporal lobar degeneration and Alzheimer's disease.

Giraldo M, Lopera F, Siniard AL, Corneveaux JJ, Schrauwen I, Carvajal J, Muñoz C, Ramirez-Restrepo M, Gaiteri C, Myers AJ, Caselli RJ, Kosik KS, Reiman EM, Huentelman MJ.

Neurobiol Aging. 2013 Aug;34(8):2077.e11-8. doi: 10.1016/j.neurobiolaging.2013.02.016. Epub 2013 Apr 9.

50.

Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional study.

Fleisher AS, Chen K, Quiroz YT, Jakimovich LJ, Gomez MG, Langois CM, Langbaum JB, Ayutyanont N, Roontiva A, Thiyyagura P, Lee W, Mo H, Lopez L, Moreno S, Acosta-Baena N, Giraldo M, Garcia G, Reiman RA, Huentelman MJ, Kosik KS, Tariot PN, Lopera F, Reiman EM.

Lancet Neurol. 2012 Dec;11(12):1057-65. doi: 10.1016/S1474-4422(12)70227-2. Epub 2012 Nov 6.

Supplemental Content

Loading ...
Support Center